Early discontinuation of immune checkpoint inhibitor therapy prior to disease progression in patients with metastatic non-small cell lung cancer: a survival analysis

ABSTRACT:

SUBMITTER: McKinley B 

PROVIDER: S-EPMC11224446 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature